Brand-New bioLIVE China in 2019
LEADING THE BIOPHARMACEUTICAL TRENDS IN AISA

In recent years, with the rapid development of cutting edge bio technologies and the mass emerge of new target drugs and cytotherapies, the biopharmaceutical industry is entering a blooming new age. In view of the global marketing size, the sales of biopharmaceutical drugs are expected to exceed 1/3 of the overall drug sales income. As per the statistics by InSight, the registrations of domestic bio drugs counted for 616 in year 2017, which exceeded the highest in the recent 5 years. As is predicted by Frost & Sullivan, the market size of China’s bio drugs will reach 326.9 billion RMB, with its increase rate ranking among the highest countries in the world.

In 2019, the brand new bioLIVE China will be launched, as an upgrade from the seven-year-old biopharmaceutical platform BioPh China. bioLIVE China 2019 will focus on life science & technology and innovative drugs, aiming to lead industrial trends and booster development in the biopharmaceutical area.

EXHIBITOR PROFILE

Biologics and New Therapies

  • Recombinant Protein
  • Polypeptide
  • Nucleic Acid
  • Vaccines
  • Plasma
  • Antibodies
  • Cell and Gene Therapy
  • Tumor Immunotherapy
  • Stem Cell & iPS

Bioprocessing, Manufacturing and Solutions

  • Cell Culture Media
  • Biological Reagents
  • Laboratory Consumables
  • Bioreactors
  • Bioseparation
  • Protein Purification
  • Bioprocessing
  • Software and Service

Biotechnology and R&D services

  • Molecular Biology
  • Cell Biology
  • Proteomics and Metabolomics
  • Biotechnology Service Platform
  • Detection Services
  • Biology Information Services
  • Drug R&D and Manufacturing
  • Clinical Research

VISITOR PROFILE

  • Top 5 Departments
  • R & D 16.67%
  • Technician/Engineer 11.79%
  • Product Manager 7.64%

2019 EXHIBITOR LIST (PARTIAL)

Extend Industry Connections with Industry Elites

  • A gathering of high-end pharmaceutical ecosystem with half of attendees having decision making power
    Manager/Project Manager/Head of Department 30.09%
    CEO/President/Board Member/General Manager 19.60%

World-Class Annual Feast Gathering International Buyers

地图

HOT EVENTS

WHAT’S NEW IN 2019?

  • Hot issues delivered: Bioscience, Biotechnology, New drugs and Bioprocessing & Manufacturing, etc.
  • Showing cutting-edge products and technology in biopharmaceutical industry.
  • Multiple types of sharing: keynotes, case studies, panel discussions, road shows, etc.
  • 50+ eminent speakers from biopharmaceutical industry
  • 800+ pharmaceutical elites attending.

X